ITX-5061

N/A

Report date: 2022/08/12 16:33:07
NME

Base Information

Drug NameITX-5061
Drug Alias NameITX-5061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionScavenger receptor class B member 1 antagonists
TargetsScavenger receptor class B member 1
Therapy Area/IndicationsHepatitis CRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesItherx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesItherx Pharmaceuticals IncUniversity Of BirminghamNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHepatitis CRejection of liver transplantation

Other Information

ATC CodeN/A
Related LinksN/A